Literature DB >> 10799624

Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group.

K B Laupland1, H D Davies, D E Low, B Schwartz, K Green, A McGeer.   

Abstract

OBJECTIVES: To describe the incidence and clinical features of invasive group A streptococcal (GAS) disease in children in Ontario and determine the risk of invasive GAS infection following chickenpox.
METHODS: During 1992-1996, we conducted prospective, active, population-based surveillance for pediatric invasive GAS disease in Ontario, Canada (population: 11 million; 2.5 million children) and reviewed clinical and laboratory records.
RESULTS: There were 1.9 cases of invasive GAS disease per 100,000 children per year. Streptococcal toxic shock syndrome (STSS) occurred in 7% of cases and necrotizing fasciitis (NF) in 4% for incidences of.08 and.13 per 100,000 per year, respectively. Case-fatality rates were 56% for STSS, 10% for NF, and 4% overall. The presence of chronic underlying illness other than asthma was associated with death (relative risk [RR]: 11; 95% confidence interval [CI]: 2.4-45). Fifteen percent of children identified had preceding chickenpox infection, which significantly increased the risk for acquisition of invasive GAS disease (RR: 58; 95% CI: 40-85). Children with invasive GAS and recent chickenpox were more likely to have NF (RR: 6.3; 95% CI: 1.8-22.3).
CONCLUSIONS: Childhood invasive GAS disease occurs at an incidence similar to the adult population but has a lower rate of STSS and case-fatality. Chickenpox dramatically increases the risk for acquiring invasive GAS disease, and universal chickenpox vaccination could potentially prevent up to 15% of all pediatric invasive GAS disease.

Entities:  

Mesh:

Year:  2000        PMID: 10799624     DOI: 10.1542/peds.105.5.e60

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  42 in total

1.  Chickenpox vaccination, not chickenpox, should be routine for Canadian children.

Authors:  B J Law
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

2.  On the trail of necrotizing fasciitis in children.

Authors:  J Ray
Journal:  CMAJ       Date:  2001-01-23       Impact factor: 8.262

3.  Flesh-eating disease: A note on necrotizing fasciitis.

Authors:  H D Davies
Journal:  Can J Infect Dis       Date:  2001-05

4.  Canada's first universal varicella immunization program: Lessons from Prince Edward Island.

Authors:  Lamont Sweet; Peggy Gallant; Marie Morris; Scott A Halperin
Journal:  Can J Infect Dis       Date:  2003-01

5.  Flesh-eating disease: A note on necrotizing fasciitis.

Authors:  H D Davies
Journal:  Paediatr Child Health       Date:  2001-05       Impact factor: 2.253

Review 6.  Current insights in invasive group A streptococcal infections in pediatrics.

Authors:  Anne Filleron; Eric Jeziorski; Anne-Laure Michon; Michel Rodière; Hélène Marchandin
Journal:  Eur J Pediatr       Date:  2012-02-25       Impact factor: 3.183

7.  Group A streptococcal bacteremia without a source is associated with less severe disease in children.

Authors:  Stefanie Gauguet; Asim A Ahmed; Jing Zhou; Elizabeth R Pfoh; Kathryn K Ahnger-Pier; Marvin B Harper; Al Ozonoff; Michael R Wessels; Grace M Lee
Journal:  Pediatr Infect Dis J       Date:  2015-04       Impact factor: 2.129

8.  Population-based surveillance of invasive group A streptococcal disease in British Columbia: 1996 to 1998.

Authors:  G L Bjorson; D W Scheifele; A Bell; A King
Journal:  Can J Infect Dis       Date:  2001-07

9.  Three-year follow-up of protection rates in children given varicella vaccine.

Authors:  David W Scheifele; Scott A Halperin; Francisco Diaz-Mitoma
Journal:  Can J Infect Dis       Date:  2002-11

10.  Invasive group a streptococcal infections, Israel.

Authors:  Allon E Moses; Sara Goldberg; Zinaida Korenman; Miriam Ravins; Emanuel Hanski; Mervyn Shapiro
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.